49 filings
8-K
NMRA
Neumora Therapeutics Inc.
14 Jun 24
Submission of Matters to a Vote of Security Holders
4:01pm
10-Q
2024 Q1
NMRA
Neumora Therapeutics Inc.
Quarterly report
7 May 24
4:01pm
8-K
NMRA
Neumora Therapeutics Inc.
7 May 24
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:15am
DEFA14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
8-K
ttsck1se5 m2
15 Apr 24
Other Events
6:46am
S-8
7vlm80jy
7 Mar 24
Registration of securities for employees
4:34pm
10-K
x54 avzyufj9te
7 Mar 24
Annual report
4:05pm
8-K
vpzlaurajazmohej3so
7 Mar 24
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023
7:08am
8-K
lxjojg wh
8 Jan 24
Regulation FD Disclosure
8:32am
8-K
rxybq39u7irj 7w9
28 Nov 23
Other Events
4:21pm
10-Q
ojdmwpz
1 Nov 23
Quarterly report
4:05pm
8-K
qt2 x3lg8uko
1 Nov 23
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:01pm
S-8
g938 2hjt83h
19 Sep 23
Registration of securities for employees
9:57pm
8-K
fdik2rwttfrq 18hz7vd
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
gtubuo35uj4mck
18 Sep 23
Prospectus supplement with pricing info
4:12pm
EFFECT
rqw2npknhi9k00mkf1
18 Sep 23
Notice of effectiveness
12:15am
CERT
qx7ygfbu1pjarhiyah
14 Sep 23
Certification of approval for exchange listing
2:03pm
SEC STAFF LETTER
rsefc8ou6fm
14 Sep 23
SEC staff letter
12:00am
8-A12B
60nle kxddb
13 Sep 23
Registration of securities on exchange
5:00pm